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On 17 October 2005, a research col-
loquium* was held on the National 
Institutes of Health campus to review 
the primary cicatricial alopecias 
(CICALs) — their etiology, their patho-
genesis, and directions for future 
research. In this rare, but important, 
group of inflammatory hair disorders, 
the hair follicle and its sebaceous gland 
are replaced by fibrous tissue, leading 
to permanent destruction of the pilo-
sebaceous unit. The cause and patho-
genesis of these diseases are unknown. 
Although treatments may arrest signs 
and symptoms of the CICALs, they do 
not usually influence the underlying 
disease process and may not arrest pro-
gression of the disease.
Participants came from around the 
world. The meeting was organized into 
major topics: Clinical and Histological 
Presentation of CICAL in Humans 
and Animal Models; Pilosebaceous 
Apparatus Growth and Structure; 
Mechanisms; and, finally, Hypotheses 
and Research Directions.
S. Katz, director of the 
National Institute of Arthritis and 
Musculoskeletal and Skin Diseases 
(Bethesda, MD), opened the meet-
ing with comments underscoring the 
paucity of epidemiological, clinical, 
and laboratory studies of these follicu-
lar diseases and the therapeutic chal-
lenge they present. P. Mirmirani (Case 
Western Reserve University, Cleveland, 
OH) the meeting organizer, put a chal-
lenge to the attendees to consider, in 
light of the colloquium’s presentations 
and discussions, (1) what mechanistic 
directions might be indicated at this 
time, and (2) what steps should be 
taken to improve our understanding 
and therapy.
The clinical and histological charac-
teristics of the CICALs were reviewed 
by V. Price (University of California, San 
Francisco). The CICALs have been divid-
ed into lymphocytic and neutrophilic 
subtypes based on pathological chang-
es. Price emphasized that the nosology 
is difficult because the histological find-
ings do not distinguish the various clin-
ical forms beyond separating the pre-
dominantly lymphocytic group from the 
predominantly neutrophilic group. As 
a rough guide to therapy, the former is 
treated with immunomodulating agents 
and the latter with antimicrobials; how-
ever, even the response to treatment is 
not always predicted by the histology. 
The concept that the CICALs may be a 
final common pathway for a number of 
different processes was raised. Not only 
is it unclear whether the follicle injury 
is due to intrinsic or extrinsic factors, 
but it is also unclear whether the fibros-
ing events are primary or secondary to 
inflammation. Knowledge of these rare 
disorders is further confounded by geo-
graphic and racial factors that influence 
epidemiology. The importance of esti-
mating the true incidence of CICAL was 
noted. Barriers to achieving this include 
a lack of the expertise necessary to 
make an accurate diagnosis and the 
poor clinicopathological correlation. 
Price stressed the need to distinguish 
clinical variants with specific chemo-
kines, and molecular markers gleaned 
from microarray-based approaches.
J.T. Headington (University of 
Michigan, Ann Arbor, retired) presented 
an overview of mechanistic, nosologi-
cal, and clinical aspects of these dis-
eases. He indicated that pathogenic 
mechanisms in CICALs involve a com-
mon pathway that leads to irreversible 
damage of both the hair matrix and the 
follicular stem cells, resulting in generic 
“cirrhosis” of the scalp. He questioned 
how and why lymphocytes or neutro-
phils effect destruction of follicular 
units and whether these infiltrates are 
just late, secondary responses to some 
other event.
A comprehensive review of animal 
models — spontaneous and induced 
— that manifest CICAL was presented 
by J. Sundberg (The Jackson Laboratory, 
Bar Harbor, ME). He pointed out 
the numerous examples of correla-
tion between mouse and human hair 
disorders. Two mouse models with 
mutations of genes expressed in the 
sebaceous gland, the stearyl-coenzyme 
A desaturase gene and gasdermin 3 (a 
transcription factor), exhibit histologi-
cal changes mirroring those in human 
lymphocytic CICALs. These studies 
implicate the sebaceous gland as the 
first injury site in the pathogenesis of 
mouse CICAL. CICAL in C57BL/6 sub-
strains shows progressive hair loss over 
the dorsum with changes reminiscent of 
central centrifugal CICAL. This appears 
to be a complex polygenic disorder 
influenced by diet and environment. An 
unresolved issue is how to manipulate 
mouse skin to mimic potential extrinsic 
factors that may be related to develop-
ment of CICAL (for example, heat and 
chemical injury).
The role of cutaneous stem cells 
in the evolution of CICALs was pre-
sented by G. Cotsarelis (University of 
Pennsylvania, Philadelphia). Reviewing 
over a decade of work on the follicular 
stem cell, Cotsarelis pointed out that 
epidermal stem cells and hair follicle 
stem cells are distinct populations. 
Recent studies using lineage analysis 
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have demonstrated that follicular stem 
cells contribute to epidermal growth 
only after injury. The role of hair fol-
licle stem cells in human CICALs 
remains to be determined, but the fact 
that inflammation in these disorders 
generally involves the bulge area and, 
in some cases, such as graft-versus-host 
disease, specifically targets epithelial 
stem cells raises the possibility that 
bulge-cell death may be one pathway 
leading to permanent loss of the fol-
licle. Experimental evidence support-
ing this concept was presented. When 
follicular stem cells are destroyed by 
targeting with a thymidine kinase sui-
cide gene under the control of the 
keratin 15 promoter, a complete loss 
of the follicle and sebaceous gland 
ensues within a relatively short period 
of time (1 week). The epidermis per-
sists after destruction of the bulge cells. 
When the epidermal stem cell popula-
tion is altered in another mouse model 
(the Rac-1 knockout mouse; Science 
309:933–5, 2005), total-organ growth 
reduction (follicle loss and epider-
mal atrophy) is found. That epidermal 
atrophy is not seen in CICAL suggests 
that hair follicle stem cells, but not epi-
dermal stem cells, are injured in these 
disorders. A major question remain-
ing is whether the stem-cell injury is a 
primary specific event or a bystander 
effect of destruction or injury of other 
portions of the follicle.
J. Schweizer (German Cancer 
Research Center, Heidelberg) presented 
a review of the keratins expressed in the 
hair follicle. Specific hair keratins are 
expressed in each of the cell lineages 
of the follicle, including the three lay-
ers of the hair shaft (cuticle, cortex, and 
medulla) and the four layers of the inner 
root sheath (companion layer, Henle’s 
layer, Huxley’s layer, and cuticle). These 
precise hair follicle keratin expression 
patterns imply defined control mecha-
nisms affecting follicle structure, and 
even follicle hormone sensitivity, as 
the Ha7 promoter contains androgen-
responsive elements and is expressed in 
the medulla of the hair shaft. Schweizer 
thought it unlikely that CICALs are due 
to a problem with keratin structure 
per se, but polymorphisms in specific 
keratins or differences in their expres-
sion might theoretically compromise 
structural integrity of the follicle and 
predispose one to the breakdown of the 
follicle with rupture of epithelial com-
ponents into the dermis, causing inflam-
mation and foreign body reaction.
C. Zouboulis (Dessau Medical 
Center, Dessau/Freie Universität, Berlin) 
reviewed the physiology and morpho-
genesis of the sebaceous gland and its 
functions. He pointed out that seba-
ceous glands may communicate with 
the hair follicle and affect function, 
as suggested by the fact that (1) active 
androgens produced by the sebaceous 
gland influence dermal papilla cell 
proliferation and (2) sebaceous-gland 
cell apoptosis, and thus destruction, 
as seen in chemotherapy-induced hair 
loss (e.g. with doxorubicin) precedes 
the hair loss. Recent work indicates 
that the sebaceous gland can synthe-
size and release corticotropin-releas-
ing hormone; moreover, it makes large 
amounts of free fatty acids, is steroido-
genic, and plays a role in skin hydra-
tion, antimicrobial activity, and surface 
antioxidant properties. Whether micro-
organisms or alterations of the seba-
ceous gland-regulated innate immunity 
of the pilosebaceous unit trigger or con-
tribute to CICAL remains a question.
As the immune privilege of the hair 
follicle bulb is compromised in alo-
pecia areata, the possibility arises that 
such a disruption could also occur 
in the CICALs. B. Nickoloff (Loyola 
University, Maywood, IL) reviewed the 
elements of the follicular immune sys-
tem as well as the basis for immune 
privilege in general. Nickoloff suggest-
ed that generating a lichen planopila-
ris mouse model could be very useful, 
because such a model would more 
accurately approximate the human 
condition. He also questioned whether 
the loss of immune privilege is a prima-
ry or a secondary event in the patho-
genesis of the CICALs.
J. James (Oklahoma Medical 
Research Foundation, Oklahoma City) 
sleuthed out the possibility of an infec-
tious etiology or an immune process 
secondary to exposure to an infectious 
organism (molecular mimicry). Using 
lupus erythematosus as her experi-
mental model, James showed that a 
subclass of lupus erythematosus auto-
antibodies react with epitopes from the 
Epstein-Barr virus. In presenting these 
data, James suggested very specific and 
practical approaches to testing these 
pathways in the pathogenesis of CICAL 
by using large-scale humoral immune 
autoantigen testing, high-through-
put lymphocyte antigen recognition 
screening, and scanning for environ-
mental exposures. She also suggested a 
global approach that would test genetic 
linkage with any of the clinically spe-
cific CICAL phenotypes by using sin-
gle-nucleotide polymorphism genome 
association studies. She emphasized 
that the immune dysregulation found in 
CICAL needs to be defined.
The role of the macrophage in 
CICAL was presented by P. Mirmirani 
(Case Western Reserve University, 
Cleveland, OH). In studying a group 
of patients with lichen planopilaris, 
Mirmirani and her group, using the 
CD68 antibody, found that there were 
a large number of macrophages around 
the hair follicle and in the perifollicu-
lar sheath in patients with CICAL. To 
describe the changes molecularly, the 
group performed gene array analyses 
and found modules of expressed genes 
that are characteristic of an immedi-
ate macrophage immune response. 
Eighty percent of the identified genes 
were modulated or dependent on p53, 
implicating this pathway in the patho-
genesis of the CICALs. This research 
raises the possibility that other aspects 
of the immune system partake in the 
pathogenesis of CICALs.
K. Stenn (Aderans Research Institue, 
Philadelphia, PA) presented the sebotro-
phic hypothesis as a pathomechanism 
of the CICALs. The notion is that the 
CICALs result from obstruction of hair 
follicle outflow; in this process the seba-
ceous gland plays a central role, but the 
problem could be proximal or distal 
to this gland. Etiologies include toxin, 
immune injury, infection, and so on. 
The CICALs might fall into a group of 
obstructive folliculopathies that would 
include acne vulgaris (sebaceous fol-
licle) and the overlap syndrome follicu-
lar occlusion triad, in which sebaceous 
and terminal follicles are diseased. The 
hypothesis implicates a need to under-
stand the mechanism of follicle traffic 
outflow, hair shaft egress, and the slip-
page plane.
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At the end of the meeting, ses-
sion chairpersons summarized ideas 
developed during the meeting in 
lecture or discussion. L. Sperling 
(Uniformed Services University of 
the Health Sciences, Bethesda, MD) 
emphasized that though the differen-
tial histology is difficult, it still mer-
its incorporation in the nosology. He 
suggested that the nature of the scar-
ring response could be mechanisti-
cally important and emphasized the 
role of genetic and environmental 
factors in the etiology. M. Philpott 
(St Bartholomews and Royal London 
School for Medicine and Dentistry) 
stressed the importance of consider-
ing the sebaceous gland and follicle 
as a single unit, and the potential role 
of the defensins in CICAL pathogen-
esis. At the same time, understanding 
differences between cell types within 
follicle compartments is critical to 
following the dysregulation of the fol-
licle in CICAL. Philpott suggested that 
a better definition of the interaction 
between the follicle stem cells and the 
connective tissue sheath, and its niche, 
is needed. K. McElwee (University of 
British Columbia, Vancouver, Canada) 
questioned which comes first in the 
CICALs: an immune response or the 
injury. He expressed the need for bet-
ter animal models. He suggested that 
tissues besides the involved scalp skin, 
such as the draining lymph nodes, 
should be studied in the human dis-
ease. M. Rosenbaum (University of 
Wisconsin, Madison) commented that 
expression of the immune-suppress-
ing molecule CD200 may also play a 
role in CICAL. J. Shapiro (University of 
British Columbia, Vancouver, Canada) 
raised the issues of the origin of the 
cells that overproduce collagen and 
are involved in fibrosis, the role of 
matrix metalloproteinases and chemo-
kines, and the different susceptibili-
ties to apoptosis of different cell types 
within the follicle.
At one point in the discussion, ref-
erence was made to the work of M. 
Hardy (University of Guelph, Canada), 
who described the CICAL phenotype 
of the asebia mouse — a condition we 
now know is caused by the mutation 
of a single sebaceous gland-express-
ing gene. She concluded that that 
condition was due to a dermal-cell 
or a systemic effect. In retrospect, 
Hardy’s approach and conclusion 
should be a lesson and a caveat for 
us. Early in the colloquium the par-
able of the elephant and the six blind 
men was invoked to describe our 
current state of confusion regarding 
where we should start in defining the 
CICAL disorders. Although this collo-
quium did not remove our blindfolds, 
it did help define directions that need 
exploration, as well as some tools and 
approaches that might be productive. 
If the spirit expressed was any indi-
cator — the camaraderie, collegial 
interaction, constructive scientific 
interchange, and research anticipa-
tion seen within and outside the hall 
— then the colloquium was an unusu-
al success. Building on this comity of 
purpose, the scientists who attended 
cannot but quickly outperform the 
blind men of the parable and, in due 
course, bring this group of formidable 
disorders into focus.
*The Cicatricial Alopecia Colloquium was 
held at Lister Hill Auditorium National 
Institutes of Health, Bethesda, Maryland, 
USA 17 October 2005. Participants: 
W. Bergfeld, K. Cooper, G. Cotsarelis, 
V. Holloway, J.T. Headington, J. James, 
L. King, K. McElwee, P. Mirmirani, B. Nickoloff, 
E. Olsen, M. Philpott, V. Price, M. Rosenbaum, 
J. Schweizer, J. Shapiro, L. Sperling, K. Stenn, 
J. Sundberg, K. Washenik, and C. Zouboulis.
